LANGLEY PORTER PSYCHIATRIC HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $492.8M
- Transactions
- 21,550
- Companies
- 40
- Average per transaction
- $22,866
Who reported the payments
| Genentech, Inc. | $70,872,424 |
| Merck | $48,239,529 |
| Abbott | $30,929,414 |
| E.r. Squibb & Sons, L.L.C. | $29,010,187 |
| AstraZeneca | $27,164,109 |
| F. Hoffmann-la Roche AG | $22,337,859 |
| Pfizer | $19,712,526 |
| Gilead | $18,525,949 |
| Eli Lilly | $15,364,600 |
| Janssen Research & Development, LLC | $14,877,925 |
| Bristol Myers Squibb | $12,197,712 |
| Amgen | $11,823,519 |
| AbbVie | $11,237,804 |
| Novartis | $10,542,671 |
| Regeneron | $8,323,423 |
| Takeda Pharmaceuticals U.S.A., Inc. | $7,267,230 |
| Novo Nordisk AS | $7,077,094 |
| Biogen | $6,258,670 |
| Servier Bioinnovation | $5,304,604 |
| Astrazeneca UK Limited | $4,985,492 |
| Biomarin Pharmaceutical Inc. | $4,911,550 |
| GE HealthCare | $4,127,992 |
| Seagen Inc. | $3,798,381 |
| Roche Products Limited | $2,988,104 |
| UCB, Inc. | $2,967,252 |
| Boston Scientific | $2,926,456 |
| Incyte Corporation | $2,712,672 |
| Sanofi US Services Inc. | $2,490,733 |
| Intuitive Surgical | $2,409,608 |
| Stryker | $2,347,533 |
| Johnson & Johnson | $2,273,065 |
| Taiho Oncology, Inc. | $2,181,816 |
| Daiichi Sankyo Inc. | $2,157,942 |
| Hoffmann-la Roche Limited | $2,135,048 |
| Jazz Pharmaceuticals Inc. | $2,048,364 |
| Siemens Medical Solutions USA, Inc. | $1,867,873 |
| Edwards Lifesciences | $1,822,743 |
| Agios Pharmaceuticals, Inc. | $1,756,979 |
| Novo Nordisk US Research & Development, Inc. | $1,731,981 |
| Neurocrine Biosciences, Inc. | $1,687,852 |